Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32019R0005R(03)

Corrigendum to Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (OJ L 4, 7.1.2019)

ST/11276/2026/INIT

OJ L, 2026/90662, 5.8.2026, ELI: http://data.europa.eu/eli/reg/2019/5/corrigendum/2026-08-05/oj (ES, EN, GA, LT, MT, NL, SV)

ELI: http://data.europa.eu/eli/reg/2019/5/corrigendum/2026-08-05/oj

European flag

Official Journal
of the European Union

EN

L series


2026/90662

5.8.2026

Corrigendum to Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use

( Official Journal of the European Union L 4 of 7 January 2019 )

On page 31, Article 1, point (22)(a)(iii), concerning Article 57(1), point (o), of Regulation (EC) No 726/2004:

for:

‘(o)

checking that the conditions laid down in Union legislation on medicinal products for human use and on veterinary medicinal products and in the marketing authorisations are met in the case of parallel distribution of medicinal products for human use and on veterinary medicinal products authorised in accordance with this Regulation or, as applicable, Regulation (EU) 2019/6;’,

read:

‘(o)

checking that the conditions laid down in Union legislation on medicinal products for human use and on veterinary medicinal products and in the marketing authorisations are met in the case of parallel distribution of medicinal products for human use and of veterinary medicinal products authorised in accordance with this Regulation or, as applicable, Regulation (EU) 2019/6;’.


ELI: http://data.europa.eu/eli/reg/2019/5/corrigendum/2026-08-05/oj

ISSN 1977-0677 (electronic edition)


Top